Physician profile
Scott Norton
NPI 1497745541
$965.12
in general payments reported to CMS, 2019-2025
13 companies · $448 in 2025
The $448 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $78.29 · 2023: $142 · 2024: $297 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $886.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $236.44 | 2025 | Zoryve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $228.99 | 2022-2024 | Spevigo |
| Janssen Biotech, INC. | $191.99 | 2022-2025 | Tremfya |
| Abbvie INC. | $76.94 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $46.57 | 2024 | Sotyktu |
| Genzyme Corporation | $37.66 | 2023 | |
| Organogenesis INC. | $26.16 | 2024 | Puraply Am |
| Organon LLC | $25.32 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $24.53 | 2022 | |
| Dermavant Sciences, INC. | $21.36 | 2024 | Vtama |
| Genentech USA, INC. | $20.84 | 2024 | Erivedge |
| Biowound Solutions, INC. | $15.50 | 2025 | Bio-Connekt |
| Sun Pharmaceutical Industries INC. | $12.82 | 2023 | Winlevi, Absorica Ld |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Norton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.